MedTrace Logo

Topical Steroid Formulation and Wet Wraps

NCT02680301 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-06-18

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to

1. Compare efficacy of 0.1% triamcinolone containing wet wrap as an ointment or as a cream formulation in patients with moderate to severe atopic dermatitis
2. The relative patient/subject acceptance and adherence will also be compared between the two wet wrap types

Conditions

  • Dermatitis, Atopic

Interventions

DRUG

0.1% triamcinolone CREAM

Patients will be asked to apply a topical steroid in a cream formulation to one extremity using the wet wrap technique.

DRUG

0.1% triamcinolone OINTMENT

Patients will be asked to apply a topical steroid in a ointment formulation to one extremity using the wet wrap technique.

Sponsors & Collaborators

  • Seton Healthcare Family

    lead OTHER

Principal Investigators

  • Lucia Diaz, MD · Seton: Dell Children's Medical Center: Specially for Childrens Dermatology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2017-03-31
Completion
2018-06-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02680301 on ClinicalTrials.gov